Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Barbui

Showing results (51-60 of 107) with videos related to

Pageof 11
Sort By:
Epidemiology and Psychiatric Sciences|July 1, 2011
Why it is important to include unpublished data in systematic reviewsC Trespidi, C Barbui, A Cipriani
Epidemiology and Psychiatric Sciences|April 19, 2022
Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global levelB Todesco, G Ostuzzi, C Barbui
Pharmacopsychiatry|June 8, 2004
Amitriptyline for inpatients and SSRIs for outpatients with depression? Systematic review and meta-regression analysisC Barbui, G Guaiana, M Hotopf
The Cochrane Database of Systematic Reviews|July 20, 2007
Amitriptyline for depressionG Guaiana, C Barbui, M Hotopf
Psychological Medicine|October 30, 1998
Antidepressant agents: from tricyclics to serotonin uptake inhibitorsS Garattini, C Barbui, B Saraceno
Epidemiology and Psychiatric Sciences|September 20, 2011
What is a Cochrane review?A Cipriani, T A Furukawa, C Barbui
Epidemiology and Psychiatric Sciences|April 30, 2020
Esketamine clinical trials: reply to Maju <i>et al.</i>C Gastaldon, D Papola, G Ostuzzi, et al.
Pharmacopsychiatry|March 4, 2005
Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial dataP Brambilla, A Cipriani, M Hotopf, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Low-dose neuroleptic therapy and relapse in schizophrenia: meta-analysis of randomized controlled trialsC Barbui, B Saraceno, A Liberati, et al.
Epidemiology and Psychiatric Sciences|July 14, 2012
What is a multiple treatments meta-analysis?A Cipriani, C Barbui, C Rizzo, et al.
Pageof 11

Showing results (51-60 of 107) with videos related to

Sort By:
Pageof 11
Epidemiology and Psychiatric Sciences|July 1, 2011
Why it is important to include unpublished data in systematic reviewsC Trespidi, C Barbui, A Cipriani
Epidemiology and Psychiatric Sciences|April 19, 2022
Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global levelB Todesco, G Ostuzzi, C Barbui
Pharmacopsychiatry|June 8, 2004
Amitriptyline for inpatients and SSRIs for outpatients with depression? Systematic review and meta-regression analysisC Barbui, G Guaiana, M Hotopf
The Cochrane Database of Systematic Reviews|July 20, 2007
Amitriptyline for depressionG Guaiana, C Barbui, M Hotopf
Psychological Medicine|October 30, 1998
Antidepressant agents: from tricyclics to serotonin uptake inhibitorsS Garattini, C Barbui, B Saraceno
Epidemiology and Psychiatric Sciences|September 20, 2011
What is a Cochrane review?A Cipriani, T A Furukawa, C Barbui
Epidemiology and Psychiatric Sciences|April 30, 2020
Esketamine clinical trials: reply to Maju <i>et al.</i>C Gastaldon, D Papola, G Ostuzzi, et al.
Pharmacopsychiatry|March 4, 2005
Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial dataP Brambilla, A Cipriani, M Hotopf, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Low-dose neuroleptic therapy and relapse in schizophrenia: meta-analysis of randomized controlled trialsC Barbui, B Saraceno, A Liberati, et al.
Epidemiology and Psychiatric Sciences|July 14, 2012
What is a multiple treatments meta-analysis?A Cipriani, C Barbui, C Rizzo, et al.
Pageof 11